Font Size: a A A
Keyword [Imatinib-mesylate]
Result: 41 - 60 | Page: 3 of 5
41. Efficacy And Safety Of High Dose Imatinib In Chronic Myeloid Leukemia Of The Meta-analysis
42. Patient Adherence To Imatinib Therapy In Chronic Phrase Of Chronic Myeloid Leukemia
43. Explore The Relationship Between The Calcium-activated Chloride Channels DOG1 And Proliferation Of Gastrointestinal Stromal Tumors(GISTs)
44. A Cost-effectiveness Analysis Of Dasatinib For The Treatment Of Imatinib Mesylate Resistant Chronic Myelogenous Leukaemia
45. 1、a Case Of Lichen Planus Induced By Imatinib Mesylate 2、influence Of Long Term Arsenite Stimulation On HaCaT Cell Proliferation, Apoptosis And Ginsenoside Rg3’s Intervention Effects Of Arsenic On HaCaT Cells
46. Establishment And Characteristic Of Imatinib Mesylate-resistant Gastrointestinal Stromal Tumor Cell
47. The Role Of HNRPDL In Malignant Cells
48. The Influence Of TET2 On The Growth Of CML Cells
49. The Role Of ZFX In Chronic Myeloid Leukemia Stem/progenitor Cells
50. The Effect Of Imatinib Mesylate On Complicance Of Neurogenic Bladder Caused By Spinal Cord Injury On Rats
51. Clinical Observation And Analysis Of Generic Imatinib Mesylate Capsules Produced In China For Newly Diagnosed CML Patients
52. The Clinical Research Of Imatinib Mesylate In Children Chronic Myelogenous Leukemia
53. A Retrospective Study On The Biological Characteristics And Comprehensive Diagnosis And Treatment Of Gastrointestinal Stromal Tumors(with 1260 Reports)
54. Clinical Significance Analysis Of Chromosomal Karyotype And ABL Kinase Mutation In 194 Patients With CML
55. Study Of Imatinib Mesylate Loaded In Hollow Mesoporous Silica Nanoparticles As Carriers System And Analytical Method
56. Clinical Analysis Of Factors Influencing The Prognosis Of Gastrointestinal Stromal Tumors
57. Effect Of Imatinib On Pulmonary Vascular Remodeling In Rats With Pulmonary Hypertension By Inhibiting Warburg Effect
58. Effects Of Silencing TUFM On GIST-T1 Cells
59. The Effects Of Imatinib Mesylate On Foxp3~+ Regulatory T Cells And Their Subtypes In The PBL Of Patients With Gastrointestinal Stromal Tumor
60. Clinical Application Of Imatinib Mesylate In The Treatment Of High Risk Gastrointestinal Stromal Tumors Before Operation
  <<First  <Prev  Next>  Last>>  Jump to